(Q64217335)
Statements
An Open-label, Non-randomized, Phase I/II Study of Allogeneic Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSC) and Liberation Therapy (When Associated With Chronic Cerebrovascular Venous Insufficiency) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) (English)
0 references
February 2015
0 references
February 2017
0 references
69
0 references
18 year
0 references
60 year
0 references